ysis of all available electrocardiograms (ECG), Holterrecordings and other medical documentation recorded before the procedure.
Ablation
All AADs were discontinued 2-3 days prior to the ablation. Left-sided pathways were accessed from the ventricular aspect, retrogradely from the femoral artery and aorta. Right-sided pathways were approached from the atrial side through the femoral vein.
Intracardiac mapping was conducted using a 4-mm tip ablation catheter (RF Marinr MC, Medtronic Inc., U.S.A.). A RF current generator (Atakr/Atakr II, Medtronic Inc., U.S.A.) with temperature-guided energy application was used. The preselected temperature was 50-60°C with power output limit 30-60 W. Preferably RF was applied during a sinus rhythm at the site with established intracardiac criteria [1] . Where the loss of preexcitation was not observed within 20 seconds, RF delivery was stopped; otherwise, RF application was continued up to 60-120 seconds. Programmed electrical stimulation from the right atrium and ventricle was performed 30 minutes after the ablation to confirm stable pathway block and to exclude other sustained arrhythmias.
The pathway location was determined based on the catheter-tip position at successful RF application, using suggested nomenclature [8] . For the purposes of the study, all ablation data from repeated procedures were added and analyzed as cumulative values per patient.
Follow-up
Initially, no AADs were prescribed after successful procedure. The follow-up began on the first day after final ablation and ended on the day of the last visit. The follow-up was based principally on periodic ECG recordings and symptoms; all patients were regularly seen in our outpatient clinic after 1, 3, 6 months and, thereafter, yearly after the procedure. The reappearance of delta-wave or reciprocating tachycardia during the follow-up was considered a recovery of AP conduction. In symptomatic patients, attempts were made at identifying causal relationship between complaints and underlying arrhythmia by repeated examinations, review of all recorded ECGs with ongoing symptoms and by Holter-recordings or hospital observation, if needed. When arrhythmia had been documented by 12-lead ECG, its origin was assessed by analysis of P-wave and/or QRScomplex morphology, using the ECG-guided algorithms [9] [10] [11] [12] . Post-ablation finding of arrhythmia, already registered before the procedure, was considered an arrhythmia recurrence, while post-ablation finding of arrhythmia, not recorded before the procedure, was considered a NA.
Statistical analysis
Descriptive statistics are presented as mean ±SD for continuous variables and counts with percentages for categorical variables. In case of normally distributed variables, the unpaired t-test, otherwise, the Mann-Whitney U-test was used. Differences in categorical variables were evaluated by chi-square or Fisher's test, as appropriate. A twotailed p-value <0.05 was considered statistically significant.
ROC curves were used to define the cut-off point in continuous variable before its dichotomization. Eventfree survival probability was estimated using the KaplanMeier curves and differences between survival curves were assessed by log-rank test. Cox proportional hazards regression analysis was used to identify predictors of NA. In patients with >1 NA, the time period from ablation to the first recorded NA was considered. Those variables that showed a potentially predictive value in the univariate analyses (p≤0.1) were included in the multivariate forward model and independent predictors were defined (p<0.05). All statistical analyses were performed using SPSS/PC 10.0 software.
RESULTS
The study population consisted of 124 patients (88 men) who met the recruitment criteria. The mean age at ablation was 43±14 years, ranging from 16 to 77. The baseline patients' characteristics are presented in Table 1 .
Before the ablation, 82% of the patients complained of orthodromic tachycardia, 12% of antidromic tachycardia, 40% of AF, 5% of atrial flutter (AFL), 5% of ventricular premature beats (VPBs) and 5% was successfully resuscitated of ventricular fibrillation. Associated structural heart Values are expressed as X±SD or n (%).
AVRT -atrioventricular reentrant tachycardia; AP -accessory pathway disease and co-morbidities were found in 15% and 32% of the patients, respectively. The procedure was repeated in 20 patients (16%). There were no differences in cumulative ablation parameters in patients with and without NAs ( Table 2) .
Over the follow-up of 4.3±3.4 years (ranging from 1.0 to 12.7 years), six patients died; the mean time from procedure to death was 5.2±2.9 years (1.9-9.1 years). One male, known for coronary disease and new post-ablation AF, suddenly died at the age of 70 years. Other patients died of non-cardiac causes.
New arrhythmias after ablation
Overall, during the follow-up, arrhythmias were revealed in 30 of 124 patients (24.2%). The arrhythmia recurrence was registered in 11 patients (8.9%), including seven with AF, one with typical AFL and three with VPBs of the same QRS-morphology as before the ablation. However, 20 patients (16.1%) experienced the NAs following ablation; in three of these patients two different forms of NAs were recorded and, therefore, a total of 23 NA cases were identified. In a single patient both recurrent arrhythmia and NA were detected.
The mean time from procedure to NA appearance was 20±29 months (ranging from two days to eight years). In 16 of 20 patients (80%) NA was recorded within the first post-ablation year. Detailed characteristics of NA patients are presented in Table 3 . On the symptomatic basis, in 90% of these patients AAD therapy was reinstituted or additional interventional treatment was undertaken.
In a 52-year-old male (0.8%), third degree AV-block coupled with syncope was registered 6 years after ablation of right midseptal AP (patient 2 in Table 3 ).
New ventricular arrhythmia was diagnosed in 9 patients (7.3%); only one of these patients was previously known for structural heart disease. Sustained ventricular tachyarrhythmias were not recorded after the procedure. However, non-sustained monomorphic ventricular tachycardia of slow rate (100 bpm) was noted in a single patient, while isolated VPBs were found in the remaining eight patients.
New atrial premature contractions (APC) were recorded in two patients (1.6%), free of structural heart disease. Eventually, in one of these patients, new APCs culminated in AF. In total, new AF was documented in four of 74 patients without AF at baseline (5.4%); the mean age at the new AF onset was 65±5 years and two of these were known for structural heart disease. In another, otherwise healthy patient (0.8%), new typical AFL evolved following ablation. In additional six patients (4.8%) daily activities were limited by inappropriate sinus tachycardia not registered before the procedure; previously, one of these patients was known for essential hypertension. 
Predictors for new arrhythmia occurrence
Univariate analysis showed that age at ablation ≥35 years (p=0.038), pre-ablation history of tachyarrhythmias >10 years (p=0.021) and septal AP location (p=0.012) were significantly related to NA occurrence, while left freewall pathway location (p=0.042) was a favourable marker. However, multivariate Cox regression analysis revealed only two independent predictors for NA occurrence: 1) septal AP location (HR=4.25; 95%CI: 1.66-10.88; p=0.003), and 2) pre-ablation duration of symptoms >10 years (HR=3.54; 95%CI: 1.27-9.88; p=0.016). The global actuarial curve for freedom from NA is shown in Graph 1. After a mean one-year follow-up eventfree survival was 87.1% (81.2-93.0%), at two years 84.6% (77.9-91.3%) and at six years 82.2% (74.2-90.2%). In addition, the patients with shorter pre-ablation history of tachyarrhythmias (≤10 years) showed better event-free survival, compared to the patients with a longer history of tachyarrhythmias before the procedure (p=0.014), Graph 2. Graph 3 shows better event-free survival after ablation of free wall APs, then after septal APs ablation (p=0.0075). Finally, the event-free survival was significantly worse in patients of age ≥35 years at procedure than in patients who were treated at a younger age (p=0.021), Graph 4.
Origin of new arrhythmias
Twelve-lead ECG and Holter-recording during arrhythmia were available for analysis in 18 (78.2%) and five (21.8%) of 23 NA cases, respectively. In four of these cases (patients 2, 4, 5 and 12 in Table 3 
DISCUSSION
Previous long-term studies after successful AP ablation have focused mainly on the recurrence of pathway conduction [2, 3] and relapse of AF [13, 14] , while development of NAs was not evaluated extensively. It was reported that late after permanent AP elimination, 13% of patients complained of short bouts of palpitations different from the pre-ablation period [2] . The noninvasive investigations showed isolated or short runs of atrial or ventricular premature beats or normal sinus rhythm related to symptom recurrence in 48% of these patients. However, in 52% of symptomatic patients symptom-related arrhythmias remained undetermined.
In the present study NAs were found in 16% of the patients during the mean follow-up of 4.3 years after successful AP ablation. The NAs occurred between two days and eight years after the procedure, but in the majority of patients (80%) these arrhythmias occurred within the first post-ablation year, which was the minimal followup time required for all patients in this study. Therefore, longer follow-up would probably identify a small number of new patients with NAs. Although benign arrhythmias (i.e. sinus tachycardia, isolated VPBs and paroxysmal AF) were encountered most frequently and sustained ventricular tachyarrhythmias were not recorded in this study, there was one case of late progression of AV-block, accompanied by syncope. Noteworthy, in 90% of NA patients, additional pharmacological or interventional treatment was required after AP elimination, mainly on the symptomatic basis. It was recognized that patients with a clinical history of paroxysmal supraventricular tachycardias are very susceptible to irregular heart beat after successful ablation and are more easily treated with drug therapy for any arrhythmia after the procedure [5, 15] . These patients may develop an increased level of discomfort during normally innocent and asymptomatic arrhythmias that they have learned to recognize as triggers of tachycardia before ablation.
The present study identified two independent predictors for NA occurrence after RF ablation of AP: 1) pre-ablation history of tachyarrhythmia-related symptoms >10 years; and 2) septal pathway location. Table 3 . Eighteen months following procedure, 24-hour Holter-monitoring revealed more than 40,000 symptomatic ventricular premature beats (VPBs), not recorded before the procedure and ECG showed VPBs (bottom panel, asterisks) of left posteroseptal morphology [13] . Note that QRS-morphology of VPBs is very similar to delta-wave morphology before ablation. Thus, the VPBs focus could be in the close proximity to previous ablation target (i.e. AP) and delayed on-site arrhythmic side-effect of an old RF lesion seems possible.
It is well known that the prevalence of cardiac arrhythmias in overall population increases with aging [16, 17] . Although older age at ablation (≥35 years) was found by univariate analysis to implicate higher risk for NA occurrence in the present study, this was not maintained in the multivariate model. Therefore, longer pre-ablation history of symptoms in NA patients may not be simply the function of their older age at the procedure. We speculate that prolonged history of pathway-mediated tachyarrhyhmias could promote myocardial changes, making the heart susceptible to NAs after AP ablation. Analogously, it was reported that patients with relapses of AF after AP ablation had more frequent palpitation attacks per month before the procedure [13] . These findings concordantly suggest that early intervention in symptomatic patients may prevent later development of arrhythmias after AP elimination.
It has been reported that ablation of septal targets can be followed by the appearance of inappropriate sinus tachycardia in 8-21% of the patients [18, 19] , as well as by increase in ventricular ectopic activity [20] . In addition, over the 10-year follow-up after AVNRT ablation using RF, late AV-block and new supraventricular arrhythmias were registered in 1.7% and 24% of the patients, respectively [5] . It is suggested that interatrial septum in humans is rich in autonomic innervation and that autonomic nerves become sparser as one moves along the AV-grooves toward the free walls [18] . Inadvertent destruction of septal autonomic fibres by RF may lead to transient parasympathetic dennervation of the heart, sometimes lasting more than one year [18] [19] [20] [21] . In accordance with the aforementioned reports, the present study identified the septal AP location as the strongest independent predictor for NA occurrence after ablation (HR=4.25). Therefore, closer follow-up of patients after septal pathways ablation seems reasonable.
A RF lesion is characterized by ragged edges, less clearly demarcated from the underlying normal myocardium [4] . This can cause non-uniform anisotropy, which may be responsible for slow conduction that allows (micro) reentry tachycardia to occur [5] . In four of 23 NA cases, presumed location of arrhythmic focus was found in proximity to previous RF lesion. Namely, in two cases, VPBs of right midseptal and left posteroseptal QRS-morphology were recognized after ablation of right midseptal and left posteroseptal pathway, respectively. In the third patient, typical AFL evolved after right posteroseptal AP ablation, at the septal level of cavotricuspid isthmus, while in the forth patient, late AV-block was registered following right midseptal AP ablation. Obviously, at least in some of these cases, late on-site arrhythmic side effect of RF lesion seems possible.
Study limitations
This study has the following limitations: 1) the absence of post-ablation EP study to evaluate origin and mechanism of NAs; 2) as the follow-up was based principally on periodic ECG recordings and symptoms, underestimation of (asymptomatic) NAs was possible; 3) Holter-monitoring was not conducted systematically before and after the procedure in all patients.
CONCLUSION
This long-term follow-up study showed that symptomatic NA occurrence may influence clinical outcome in 16% of patients after definite AP ablation by RF current. Although benign arrhythmias were identified in the majority of these patients, a very late progression of AV-block was recorded. The baseline clinical and electrophysiological characteristics can help identify a subgroup of patients who are at a higher risk of developing NA after the procedure. Early intervention in symptomatic WPW-patients might reduce NA occurrence and closer follow-up with screening for NA occurrence at least in the first post-ablation year is advised after ablation of septal pathways. At least in some of NA cases, late pro-arrhythmic effect of initially curative RF lesion seems possible. These findings can help physicians inform patients properly before the procedure about possible NA occurrence, as well as on affect of the decision to ablate in asymptomatic patients with ventricular preexcitation.
